nausea and vomiting. Nausea and vomiting of children
Conditions
Interventions
Intervention 1: Each patient receives the same for an hour before the first course of 40 mg/kg body weight chemotherapy in the form of a single dose of granisetron to a maximum dose of 3 mg per dose p
Treatment - Drugs
Placebo
Each patient receives the same for an hour before the first course of 40 mg/kg body weight chemotherapy in the form of a single dose of granisetron to a maximum dose of 3 mg per dose plus placebo on d
In the control group, similar placebo was used.
Sponsors
Vice chancellor for research, Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Patients with malignancies who was under chemotherapy with 5 to 18 years of age; non-nausea due to illness with the approval of the physician; presence of a healthy vision; attending the first day of chemotherapy and nausea severity; minimum score of 20 From VAS mm100 (visual analogue scale). Exclusion criteria: Severe manifestations of complications of the epiphyte including fever, severe infection, tinnitus, deep vein thrombosis, severe digestive problems, etc; failure of the patient to determine the severity of nausea based on the instructions.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: 1, 2nd and 3rd days. Method of measurement: Recorded in checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAziz Eghbali
Amir Kabir Hospital of Arak city
Outcome results
None listed